These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 2624251)

  • 1. Prevention of graft-vs-host reaction induced immunodeficiency by treatment with splenopentin (DAc-SP5).
    Eckert R; Volk HD; Diezel W; Maciewski J; Hiepe F; Forner K; von Baehr R
    Allerg Immunol (Leipz); 1989; 35(4):279-85. PubMed ID: 2624251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Splenopentin (DAc-SP5)--influence on engraftment and graft-vs-host reaction after non-H-2 bone marrow transplantation in mice.
    Eckert R; Maciejewski J; Weber H; Volk HD; Diezel W; Forner K; von Baehr R
    Exp Clin Endocrinol; 1990 Dec; 96(3):307-13. PubMed ID: 2083570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Splenopentin-induced reconstitution of the immune response after total body irradiation: optimization of treatment regime.
    Eckert R; Schmidt R; Volk HD; Diezel W; Sönnichsen N; von Baehr R
    Exp Clin Endocrinol; 1989 Sep; 94(1-2):223-5. PubMed ID: 2689192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of splenopentin (SP-5) on the antibody formation in immunosuppressed mice.
    Diezel W; Eckert R; Forner K; Sönnichsen N
    Exp Clin Endocrinol; 1986 Jul; 87(2):215-8. PubMed ID: 3489630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histamine receptor-bearing lymphocytes (HRL). VIII. Splenopentin-accelerated reconstitution of the immunoresponsiveness after elimination of HRL.
    Eckert R; Diezel W; Forner K; Pfüller U; Sönnichsen N; von Baehr R
    Allerg Immunol (Leipz); 1986; 32(4):267-70. PubMed ID: 2951991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Splenopentin (DAc SP-5)-accelerated reconstitution of antibody formation after syngeneic bone marrow transplantation.
    Eckert R; Diezel W; Schmidt R; Forner K; Volk HD
    Exp Clin Endocrinol; 1989 Sep; 94(1-2):219-22. PubMed ID: 2689191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic possibilities of thymopoietin fragments (TP3 and TP4) based on experimental animal models.
    Dénes L; Szende B; Hajós G; Szporny L; Lapis K
    Drugs Exp Clin Res; 1987; 13(5):279-87. PubMed ID: 3500029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Splenopentin--influence on antibody formation in immunosuppressed animals and on phagocytic capability of human granulocytes.
    Diezel W; Eckert R; Müller GM; Forner K; Sönnichsen N
    Arch Geschwulstforsch; 1989; 59(3):161-4. PubMed ID: 2667491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation and suppression of graft-vs-host reactions by cyclophosphamide.
    Wander RH; Hilgard HR
    J Immunol; 1981 Mar; 126(3):901-4. PubMed ID: 7462635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of polyinosinic:polycytidylic acid (pI:C) on the graft-vs-host (GVH) reaction. II. Increased NK-mediated rejection on C57BL/6 lymphocytes by (C57BL/6 X A)F1 mice.
    Peres A; Nestel FP; Seemayer TA; Lapp WS
    J Immunol; 1986 Dec; 137(11):3420-7. PubMed ID: 3537120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of F1 cytotoxic potentials by GvHR. Host- and donor-derived cytotoxic lymphocytes arise in the unirradiated F1 host spleens under the condition of GvHR-associated immunosuppression.
    Kubota E; Ishikawa H; Saito K
    J Immunol; 1983 Sep; 131(3):1142-8. PubMed ID: 6604089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunosuppressive activity of macrophages in mice undergoing graft-versus-host reaction due to major histocompatibility complex class I plus II difference.
    Ikarashi Y; Kawai K; Watanabe H; Matsumoto Y; Omata S; Fujiwara M
    Immunology; 1993 May; 79(1):95-102. PubMed ID: 8099568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recovery of T cell populations after acute graft-vs-host reaction.
    Hakim FT; Payne S; Shearer GM
    J Immunol; 1994 Jan; 152(1):58-64. PubMed ID: 8254206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reconstitution of lymphoid tissues under the influence of a subclinical level of graft versus host reaction induced by bone marrow T cells or splenic T cell subsets.
    Hirano M; Arase H; Arase-Fukushi N; Ogasawara K; Iwabuchi K; Miyazaki T; Good RA; Onoé K
    Cell Immunol; 1993 Oct; 151(1):118-32. PubMed ID: 8402923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The graft-versus-host reaction and immune function. IV. B cell functional defect associated with a depletion of splenic colony-forming units in marrow of graft-versus-host-reactive mice.
    Seddik M; Seemayer TA; Lapp WS
    Transplantation; 1986 Feb; 41(2):242-7. PubMed ID: 3511585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation of the recruitment of epidermal Langerhans cells by splenopentin.
    Gruner S; Diezel W; Strunk D; Zwirner A; Sönnichsen N; Anhalt GJ
    Arch Dermatol Res; 1990; 281(8):526-9. PubMed ID: 2322010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of L3T4+ and Lyt-2+ donor cells in graft-versus-host immune deficiency induced across a class I, class II, or whole H-2 difference.
    Moser M; Sharrow SO; Shearer GM
    J Immunol; 1988 Apr; 140(8):2600-8. PubMed ID: 3258615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Graft-vs-host reactions (GVHR) across minor murine histocompatibility barriers. II. Development of natural suppressor cell activity.
    Maier T; Holda JH; Claman HN
    J Immunol; 1985 Sep; 135(3):1644-51. PubMed ID: 3160774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Splenopentin--modification of the maturation of T helper lymphocytes?].
    Diezel W; Volk HD; Koyka I; Forner K
    Dermatol Monatsschr; 1986; 172(9):557-9. PubMed ID: 2947823
    [No Abstract]   [Full Text] [Related]  

  • 20. Graft-vs-host reactions (GVHR) across minor murine histocompatibility barriers. I. Impairment of mitogen responses and suppressor phenomena.
    Holda JH; Maier T; Claman HN
    J Immunol; 1985 Mar; 134(3):1397-402. PubMed ID: 3155767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.